GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Short-Term Capital Lease Obligation

Belluscura (FRA:9VQ) Short-Term Capital Lease Obligation : €0.00 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Belluscura Short-Term Capital Lease Obligation?

Belluscura's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was €0.00 Mil.

Belluscura's quarterly Short-Term Capital Lease Obligation increased from Jun. 2022 (€0.00 Mil) to Dec. 2022 (€0.12 Mil) but then declined from Dec. 2022 (€0.12 Mil) to Jun. 2023 (€0.00 Mil).

Belluscura's annual Short-Term Capital Lease Obligation increased from Dec. 2020 (€0.08 Mil) to Dec. 2021 (€0.10 Mil) and increased from Dec. 2021 (€0.10 Mil) to Dec. 2022 (€0.12 Mil).


Belluscura Short-Term Capital Lease Obligation Historical Data

The historical data trend for Belluscura's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Short-Term Capital Lease Obligation Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Short-Term Capital Lease Obligation
- 0.07 0.08 0.10 0.12

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only - 0.10 - 0.12 -

Belluscura Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Belluscura Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Belluscura's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Belluscura (FRA:9VQ) Business Description

Traded in Other Exchanges
Address
15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines